{"uri": "eng-9425323", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Dravet_syndrome", "type": "wiki", "score": 100, "label": {"eng": "Dravet syndrome"}}, {"uri": "http://en.wikipedia.org/wiki/Seizure", "type": "wiki", "score": 90, "label": {"eng": "Seizure"}}, {"uri": "http://en.wikipedia.org/wiki/Frequency", "type": "wiki", "score": 79, "label": {"eng": "Frequency"}}, {"uri": "http://en.wikipedia.org/wiki/Cognition", "type": "wiki", "score": 73, "label": {"eng": "Cognition"}}, {"uri": "http://en.wikipedia.org/wiki/Convulsion", "type": "wiki", "score": 69, "label": {"eng": "Convulsion"}}, {"uri": "http://en.wikipedia.org/wiki/Adolescence", "type": "wiki", "score": 67, "label": {"eng": "Adolescence"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 50, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Disease", "type": "wiki", "score": 47, "label": {"eng": "Disease"}}, {"uri": "http://en.wikipedia.org/wiki/Epilepsy", "type": "wiki", "score": 46, "label": {"eng": "Epilepsy"}}, {"uri": "http://en.wikipedia.org/wiki/Medicine", "type": "wiki", "score": 35, "label": {"eng": "Medicine"}}, {"uri": "http://en.wikipedia.org/wiki/Genetics", "type": "wiki", "score": 33, "label": {"eng": "Genetics"}}, {"uri": "http://en.wikipedia.org/wiki/Biotechnology", "type": "wiki", "score": 32, "label": {"eng": "Biotechnology"}}, {"uri": "http://en.wikipedia.org/wiki/Protein", "type": "wiki", "score": 31, "label": {"eng": "Protein"}}, {"uri": "http://en.wikipedia.org/wiki/Chief_executive_officer", "type": "wiki", "score": 25, "label": {"eng": "Chief executive officer"}}, {"uri": "http://en.wikipedia.org/wiki/Fenfluramine", "type": "wiki", "score": 22, "label": {"eng": "Fenfluramine"}}, {"uri": "http://en.wikipedia.org/wiki/Mechanism_of_action", "type": "wiki", "score": 19, "label": {"eng": "Mechanism of action"}}, {"uri": "http://en.wikipedia.org/wiki/Pediatrics", "type": "wiki", "score": 19, "label": {"eng": "Pediatrics"}}], "eventDate": "2024-03-25", "totalArticleCount": 11, "title": {"eng": "Canaccord lifts Stoke Therapeutics stock target to $21 on positive data By Investing.com"}, "summary": {"eng": "On Monday, Canaccord Genuity updated its outlook on Stoke Therapeutics (NASDAQ:STOK), increasing the price target to $21.00 from the previous $18.00 while maintaining a Buy rating on the stock. The adjustment follows Stoke Therapeutics' announcement of encouraging Phase 1/2a data for its STK-001 treatment for Dravet syndrome on Sunday.\n\nThe treatment utilizes Stoke's proprietary TANGO technology to address this condition, which currently has a high unmet medical need.\n\nAccording to the recent dat"}, "location": null, "categories": [{"uri": "dmoz/Health/Conditions_and_Diseases/Genitourinary_Disorders", "label": "dmoz/Health/Conditions and Diseases/Genitourinary Disorders", "wgt": 100}, {"uri": "dmoz/Health/Conditions_and_Diseases/Nutritional_and_Metabolic_Disorders", "label": "dmoz/Health/Conditions and Diseases/Nutritional and Metabolic Disorders", "wgt": 100}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}], "articleCounts": {"eng": 11}, "sentiment": 0.2470588235294118, "wgt": 449020800, "relevance": 2}